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Ornithine decarboxylase (ODC), a key enzyme in the biosynthesis of polyamines, is one of the most rapidly degraded proteins in mammalian cells. 
Recently it has been demonstrated that mammalian ODC is degraded in vitro by the 26s protease that contains the 20s proteasome as its catalytic 
core, in a reaction that does not require ubiquitin. Here, we show that yeast and mouse ODC are both rapidly degraded in yeast cells and that their 
degradation severely inhibited in a mutant yeast cell line defective in the chymotryptic activity of proteinase yscE, the yeast 20s proteasome. These 
results provide compelling genetic support to previous biochemical studies suggesting the involvement of the 205 proteasome in the degradation of 
ornithine decarboxylase. 
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1. Introduction 
The proteasome, a 20s multicatalytic proteinase com- 
plex found in all eukaryotic cells, is highly conserved 
during evolution from yeast to human [l-7]. This 700 
kDa cylinder-shape proteolytic particle, that consists of 
a large number of typical low molecular mass subunits, 
exhibits various proteolytic activities specific to proteins 
and peptides [7-91. The 20s proteasome was recently 
demonstrated as a constituent of an even larger prote- 
olytic conglomerate, termed 26s protease [IO-121. While 
the explicit physiological role of the free 20s particle is 
still obscure, it has been demonstrated that the 265 pro- 
tease is involved in the ATP-dependent degradation of 
ubiquinated proteins [ 13,143. So far, only two physiolog- 
ically short lived proteins, c-mos and ornithine decarbox- 
ylase (ODC), have been demonstrated as specific sub- 
strates of the 26s protease in vitro [15--l 71. Interestingly, 
while the degradation of the mos protein requires ubiq- 
uitin 1161, that of ODC is ubiquitin independent [15,17]. 
However, the involvement of the 20s proteasome, or the 
26s protease in the degradation of specific physiologi- 
cally short-lived proteins in intact cells was not yet dem- 
onstrated. 
Recently, a mutant yeast cell line, that is defective in 
the chymotryptic activity of the yeast 20s proteasome 
(proteinase yscE [IS]) was isolated. A~umulation of the 
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bulk of ubiquinated proteins in these mutant cells [18], 
and their inability to degrade ,&galactosidase derivatives 
that are substrates of the ubiquitin-dependent, N-end 
rule pathway [19,20]. indicate the involvement of the 
yeast proteasome in the ubiquitin-de~ndent proteolytic 
pathway. Here, using the yscE mutant cells, we demon- 
strate that the yeast proteasome is also involved in the 
in vivo degradation of ornithine decarboxylase. 
2. Materials and methods 
2.1. Clorzing of yeast UDC DNA 
Two synthetic oligonucleotides complementary to amino acids 111 
to 118 and 407 to 415 of Saccharomyces cereviszae ODC 1211, were used 
as opposing primers in a polymerase chain reaction (PCR). The result- 
ing 912 bp DNA fragment was used as an hybridization probe for 
screening a library prepared from EcoRI digested yeast genomic DNA. 
A 3 kb EcoRI fragment, from a positively hybridizing phage, was 
subcloned into the Bluescript plasmid (Stratagene). Restriction and 
sequence analysis demonstrated its identity to the previously isolated 
3 kb EcoRI fragment hat contains the yeast ODC gene [21]. 
2.2. Strains 
Yeast strains used were: WCG4a (MATa ura3 Iea2-3,112 h&3-iI,l5) 
or WCG4-l-la (MATa ura3 leu2-3.112 his3-II,I5prel-I). To generate 
an ODC-deficient variant, cells representing these two stains were 
transformed with a 3 kb ODC fragment in which a 1 kb ClaI-BsmI 
segment encompassing amino acids 147466, and part of the 3’ non- 
coding region, was replaced by a 1.1 kb fragment containing a func- 
tional URA3 gene. Colonies that grew in the absence of uracil were 
selected and demonstrated to lack ODC activity. The two ODC defi- 
cient cell lines were used in the presented studies. 
2.3. Expresston of mouse and yeast Oi3C proteins in yeast cells 
Mouse ODC cDNAs encoding the wild-type enzyme and the previ- 
ously described stable carboxyl-terminal deletion mutant, Del-6 [22], 
(cloned in Bluescript between the EcoRI (5’) and BamHI (3’) sites) were 
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digested with EcoRV and ligated to BumHI linkers. The resulting 
cDNA fragments, flanked by BumHI sites, were ligated to the BgflI site 
of the yeast expression vector pKV49 [23]. The 3 kb yeast ODC DNA 
fragment was digested with Hind111 (located 177 nucleotides upstream 
to the translation start site) and with SspI (located 517 nucleotides 
downstream to the stop codon). The resulting 2.1 kb fragment was 
blunted with the klenow fragment of DNA polymerase-I, ligated to 
BarnHI linkers, and cloned into the BgBI site of the pKV49 expression 
vector. Wild-type WCG4a cells and their isogenic WCG4a prel-la 
cells, that are defective m the chymotryptic activity of proteinase yscE, 
were transformed with the above described expression constructs. Since 
m these constructs the various ODCs were cloned under the regulation 
of the phosphoglycerate kinase (PGK) promoter, whose upstream acti- 
vating sequences were replaced by those of the GAL-10 promoter. 
expression is induced by galactose and completely repressed by glucose 
1231. 
2.4. Pulse-chase experiments and immunoprecipitation analysis 
A 5 ml culture (OD 6u0 = 0.5) of yeast cells grown in a minimal medium 
containing galactose, was harvested by centrifugation and incubated in 
0.5 ml of the same medium supplemented with 100,~Ci [35S]methionine. 
After 10 min of incubation, cells were harvested either immediately or 
following a chase period in a minimal medium containing glucose. The 
cells were resuspended in immunoprecipitation buffer (100 mM Tris- 
HCl pH 7.5, 150 mM NaCI, 2 mM EDTA, 1% NP40, 0.1% Triton 
X-100, 0.1% SDS), and disrupted by vortexing with glass beads. The 
extract was cleared by centrifugation and the amount of labeled pro- 
teins was determined by TCA precipitation. Portions containing equal 
amount of radioactivity were subjected to immunoprecipitation with 
anti-mouse, or anti-yeast ODC sera, prepared in rabbit against the 
respective antigens that were produced in bacteria [24]. Immunoprecip- 
itated material was resolved by electrophoresis in a 10% SDS-poly- 
acrylamide gel, and visualized by autoradiography. Each experiment 
was performed at least three times. 
3. Results 
In order to directly monitor expression and metabolic 
stability of various ODC proteins in yeast cells, cDNAs 
encoding wild-type yeast ODC, wild-type mouse ODC, 
and the stable mouse carboxyl-terminal deletion mutant, 
Del-6, [22], were cloned into the yeast expression vector 
pKV49 [23]. The resulting constructs were used to trans- 
form wild-type yeast WCG4a cells. Transformed cells 
harboring each expression construct were grown in a 
minimal medium containing galactose, and labeled with 
[35S]methionine. Cellular extracts prepared either imme- 
diately or following the indicated chase periods were 
subjected to immunoprecipitation analysis, using highly 
specific anti-mouse or anti-yeast ODC sera. All three 
ODC proteins were efficiently expressed in the trans- 
formed yeast cells (Fig. 1). Moreover, as observed in 
mammalian cells [25,26], wild-type mouse ODC was rap- 
idly degraded, while the carboxyl-terminal deletion mu- 
tant, Del-6, was stable (Fig. 1). In agreement with the 
reported rapid decay of yeast ODC activity in yeast cells 
[27], the yeast ODC protein decayed rapidly (Fig. 1). 
Subsequently, in order to determine whether the ob- 
served degradation of the wild-type mouse and yeast 
ODC proteins requires the functional integrity of the 
yeast proteasome, WCG4a prel-1 cells that are deficient 
in the chymotryptic activity of the yeast proteasome [18], 
were transformed with the expression constructs encod- 
MOUSE YEAST 
I , 
WT -_ Del-6 w 
Hours 0 1 01 02 
Fig. 1. Degradation of mouse and yeast ODC proteins in yeast cells. 
Wild-type yeast WCG4a cells were transformed with pKV49 based 
expression constructs harboring wild-type mouse ODC, its stable Del-6 
mutant and wild-type yeast ODC DNA. Transformed cells were grown 
in medium containing galactose, and labeled for 10 min with 
[35S]methionine. Cellular extracts prepared immediately, or after the 
indicated time of chase in glucose containing medium, were subjected 
to immunoprecipitation analysis using highly specific anti-mouse or 
anti-yeast ODC sera. Immunoprecipitated material was fractionated by 
electrophoresis m a 10% SDS-polyacrylamide gel, and visuahzed by 
autoradiography. The position of the immunoprecipitated ODC pro- 
teins is indicated by arrowheads. 
ing the two labile wild-type ODC proteins. Pulse-chase 
analysis revealed that in contrast to their rapid degrada- 
tion in wild-type cells, both wild-type ODC proteins were 
dramatically stabilized in the pre l-l mutant cells 
(Fig. 2). 
4. Discussion 
We demonstrate here that yeast and mouse ODC, are 
rapidly degraded in wild-type yeast cells, but are dramat- 
ically stabilized in yeast cells harboring a mutant pro- 
teasome (yscE proteinase) which is defective in its chy- 
motryptic activity. 
We show here that as demonstrated previously in 
mammalian cells, also in yeast cells mouse ODC is a 
highly unstable protein. Moreover, as in mammalian 
cells, also in yeast cells ODC degradation requires the 
carboxyl-terminal destabilizing signal [22,28]. Interest- 
ingly, yeast ODC, which shares significant homology 
with the mouse enzyme, but lacks the carboxyl-terminal 
destabilizing segment, is rapidly degraded in yeast cells. 
This suggests that the recognition of yeast ODC by the 
yeast cellular proteolytic machinery is mediated by a 
recognition signal distinct from that of the mouse en- 
zyme. 
The degradation of the unstable wild-type mouse and 
yeast ODC proteins were directly tested in the WCG4a 
prel- 1 mutant that is defective in the chymotryptic activ- 
ity of the yeast proteasome. Our results clearly demon- 
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Fig. 2. Degradation of mouse and yeast ODC in wild-type yeast and 
in the prel-1 mutant cells defective in the chymotryptic activity of 
proteinase yscE. Cells were grown in the presence of galactose and 
labeled for 10 min with [“Slmethionine. Cellular extracts were prepared 
either immediately, or following the indicated chase periods in glucose 
containing medium, and subjected to immunoprecipitation analysis as 
described in the legend to Fig. 1. The position of the ODC proteins is 
indicated by arrows. 
strate that despite the difference in the signal that medi- 
ates their recognition, the degradation of both ODC 
proteins was dramatically impaired in the mutant strain. 
Based on these results, we conclude that the 20s pro- 
teasome is involved in the degradation of ODC in yeast 
cells. Recently, multiple forms of the mammalian 20s 
proteasome and the 26s protease were demonstrated 
[29]. Therefore, it could not be presently concluded, 
whether these two ODC proteins are recognized and 
degraded by the same 20s proteolytic particle, or by 
dissimilar proteasomes. 
Recent studies have illustrated that the yeast pro- 
teasome (proteinase yscE) is involved in the degradation 
of ubiquinated proteins derived from different ubiquitin- 
dependent proteolytic pathways [ 18-201. As we present 
here, the proteasome is also involved in the degradation 
of ODC, a process shown previously to be ubiquitin 
independent in mammalian cells [17,25,26]. Interestingly, 
studies in vitro revealed that in mammalian cells the 26s 
protease, not the free 20s proteasome, is involved in the 
degradation of ubiquinated proteins [l&14], and in the 
ubiquitin independent degradation of ODC [15,17]. It 
will be challenging to determine whether, in yeast, the 
20s proteasome is directly responsible for the degrada- 
tion of ubiquinated proteins and of ODC or, whether as 
in mammalian cells, it exerts its proteolytic role as a 
constituent of a larger more complex proteolytic con- 
glomerate. 
The 20s proteasome has been shown to exhibit three 
distinct proteolytic activities, trypsin-like, chymotrypsin- 
like and peptidyl-glutamyl-peptide hydrolyzing activity. 
Our present study demonstrates that a lesion in the chy- 
motryptic activity severely inhibits ODCs degradation. 
It will be of interest to determine whether the other en- 
dopeptidase functions are also required for efficient deg- 
radation of ODC. Recently, another mutant cell line was 
isolated, showing deficiency in the peptidyl-glutamyl- 
peptide hydrolyzing activity [30]. In contrast to the prel- 
1 mutants used in the present study, which accumulate 
ubiquitin-protein conjugates under stress conditions, this 
pre4-1 mutant exhibits no stress dependent phenotype. 
This difference emphasizes the interest in testing the deg- 
radation of ODC in the pre4-1 mutant, and in additional 
mutants of the yeast proteasome. 
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